Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for January 20th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 20th:

América Móvil, S.A.B. de C.V. (AMX - Free Report) : This telecommunications services provider carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.

 

América Móvil has a PEG ratio of 0.63 compared with 1.56 for the industry. The company possesses a Growth Score of A.

 

PerkinElmer, Inc. (PKI - Free Report) : This provider of products, services, and solutions to the diagnostics, life sciences, and applied services markets carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.

 

PerkinElmer, Inc. Price and Consensus

PerkinElmer, Inc. Price and Consensus

PerkinElmer, Inc. price-consensus-chart | PerkinElmer, Inc. Quote

 

PerkinElmer has a PEG ratio of 0.97, compared with 3.42 for the industry. The company possesses a Growth Score of B.

 

PerkinElmer, Inc. PEG Ratio (TTM)

PerkinElmer, Inc. PEG Ratio (TTM)

PerkinElmer, Inc. peg-ratio-ttm | PerkinElmer, Inc. Quote

 

Focus Financial Partners Inc. (FOCS - Free Report) : This provider of wealth management services carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

 

Focus Financial has a PEG ratio of 0.91, compared with 1.78 for the industry. The company possesses a Growth Score of B.

 

Sally Beauty Holdings, Inc. (SBH - Free Report) : This specialty retailer and distributor of professional beauty supplies carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.

 

Sally Beauty has a PEG ratio of 0.24, compared with 1.06 for the industry. The company possesses a Growth Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>